Congress trades

argenx SE (ARGX)

Biotechnology, listed on NASDAQ.

5 Congress tradeslast filed Nov 11, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

CongressSTOCK Act · disclosed Nov 10, 2026

Gilbert Ray Cisneros, Jr. reported a $15,001 to $50,000 purchase of stock.

Traded Oct 14, 2026 and disclosed Nov 10, 2026, 27 days later. One of 3 disclosures Gilbert Ray Cisneros, Jr. filed on Nov 10, 2026.

Gilbert Ray Cisneros, Jr.Purchase$1,001 - $15,00014d
Gilbert Ray Cisneros, Jr.Purchase$15,001 - $50,00027d
Gilbert Ray Cisneros, Jr.Purchase$1,001 - $15,00026d

Bands as filed. Each bar is the days from trade to disclosure, against the 45 the STOCK Act allows.

5 Congress disclosures shown, from 3 members.

27dMedian delayof the 45 day limit
4 buys · 1 sellPurchases and sales in the disclosures shown

One member of Congress, Gilbert Ray Cisneros, Jr., reports a position in ARGX, by our estimate. Who holds it

Every disclosure

Money managers13F filings for Jun 30, 2026

2

of the 97 fund managers GetSignal tracks list argenx SE among their largest positions. Avoro Capital Advisors held the most, $927.8M.

Tracked managers’ Q2 2026 moves

Baker Bros.sold out−$18.4M

Each manager’s 13F against the one before, priced at the Jun 30, 2026 close: an estimate, from each manager’s 15 largest moves. Not investment advice.

Every manager

EarningsQ2 FY2026 · reported Jul 30, 2026

Q2 FY2026: Beat on EPS. Next report Feb 25, 2027.

EPS Q2 FY2026

Reported$7.80
Consensus$7.44

Beat 5Miss 1

Consensus $7.57 a share on $3.35B of revenue, the analysts’ forecast.

Every quarter
Companyfrom the company's filings and listing, as of Nov 15, 2026

About argenx SE

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
Karen Massey
Employees
1,863
Listed since
May 18, 2017
Market value
$60.3B
Price to earnings (12 mo)
45.5
Net income per share, as reported (12 mo)
$21.16
Dividend yield
-

www.argenx.com

Earnings6 reported quarters · next on Feb 25, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 30, 2026$7.80$7.44n/a$1.7BEPS beatRevenue n/a
May 7, 2026$5.90$5.16n/a$1.4BEPS beatRevenue n/a
Oct 30, 2025$5.18$4.37$948.0M$1.3BEPS beatRevenue miss
May 8, 2025$2.58$2.32$573.2M$861.8MEPS beatRevenue miss
Oct 31, 2024$1.39$0.10$401.0M$665.1MEPS beatRevenue miss
May 9, 2024-$1.04-$0.71$329.8M$563.9MEPS missRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A figure or flag reads n/a when a number is missing, or when the figure failed our check against the company's other quarters, its own filings and its share splits, and was left out. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

No earnings call briefs on ARGX yet. Briefs from every company we cover.

13F filings13F positions as of Sep 30, 2026

Institutional holders

97 institutions reported argenx SE shares in 13F filings for Sep 30, 2026.
HolderValueSharesShares vs prior qtr% of shares out
FMR LLC$5.1B5,357,529+2.4%8.62%
Capital World Investors$2.2B2,279,203+3.6%3.67%
Artisan Partners Limited Partnership$1.1B1,165,747-22.7%1.87%
BlackRock, Inc.$843.1M879,255+13.1%1.41%
Morgan Stanley$562.4M586,527-8.8%0.94%
Invesco Ltd.$401.8M419,038-5.6%0.67%
Sands Capital Management, LLC$259.1M270,206-9.5%0.43%
Bessemer Group Inc$254.0M264,846-1.1%0.43%
Franklin Templeton Inc$247.0M265,180+17.9%0.43%
William Blair Investment Management, LLC$237.2M247,401-6.5%0.40%
SEI Investments Co$214.2M223,338-12.4%0.36%
Clearbridge Investments, LLC$202.2M210,855-16.9%0.34%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Sep 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

13F filings2 managers

Tracked fund managers holding ARGX

ManagerValueSharesShare of book
Avoro Capital Advisors$927.8M1,000,0008.3%
OrbiMed$86.2M92,8801.6%

2 of the 97 fund managers we track list ARGX shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

STOCK Act5 disclosures of 5 on record · median 27d of the 45 allowed

Congress trades in ARGX

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+8.8% since the tradeEstimated entry price $882.48, close on Tue Oct 27Current price $960.04, close on Fri Nov 13Oct 27, 2026Nov 10, 202614d
Gilbert Ray Cisneros, Jr.StockPurchase$15,001 - $50,000+17.3% since the tradeEstimated entry price $818.30, close on Wed Oct 14Current price $960.04, close on Fri Nov 13Oct 14, 2026Nov 10, 202627d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+13.4% since the tradeEstimated entry price $846.27, close on Thu Oct 15Current price $960.04, close on Fri Nov 13Oct 15, 2026Nov 10, 202626d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000+36.3% since the tradeEstimated entry price $704.31, close on Mon Mar 30Current price $960.04, close on Fri Nov 13Mar 30, 2026Jul 21, 2026113d
Daniel S. GoldmanStockSale$1,001 - $15,000+148.4% since the saleEstimated exit price $386.51, close on Mon Jul 10, 2023Current price $960.04, close on Fri Nov 13Jul 10, 2023Aug 13, 202334d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in ARGX filterable by party, chamber, type and account.

STOCK Act1 member · estimate, as of Nov 15, 2026

Members of Congress reporting a position

1 member reports a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$50,001 - $100,0000.2%

The largest estimated position is in the $50,001 - $100,000 band. Estimate, as of Nov 15, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 16, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on ARGX show and how current they are.

Which members of Congress have traded ARGX?

Gilbert Ray Cisneros, Jr., Alan Armstrong and Daniel S. Goldman disclosed ARGX transactions in the filings shown here.

Which members of Congress hold ARGX?

1 member of Congress reports a position in ARGX in the estimate we hold as of Nov 15, 2026. The estimated position belongs to Gilbert Ray Cisneros, Jr. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are ARGX trades disclosed?

Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track